- Home
- CERT vs OPK Comparison
CERT vs OPK Comparison
Compare CERT & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CERT | OPK |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 860.9M | 921.2M |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CERT | OPK |
|---|---|---|
| Price | $5.86 | $1.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | ★ $11.67 | $1.60 |
| AVG Volume (30 Days) | ★ 3.5M | 2.3M |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $418,838,000.00 | ★ $606,879,000.00 |
| Revenue This Year | $4.18 | N/A |
| Revenue Next Year | $5.39 | $4.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $4.45 | $0.98 |
| 52 Week High | $13.88 | $1.60 |
Technical Indicators
Market Signals| Indicator | CERT | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 58.09 | 82.58 |
| Support Level | $5.19 | $1.25 |
| Resistance Level | $6.47 | $1.52 |
| Average True Range (ATR) | 0.36 | 0.06 |
| MACD | 0.11 | 0.03 |
| Stochastic Oscillator | 88.68 | 89.41 |
Price Performance
Historical ComparisonAbout CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.